Back

Conclusions.

30 August 2020 (13:41 - 13:45)
Organised by:
Congress Presentation Part of: How evidence from routine clinical practice can improve the care of the elderly atrial fibrillation patient? Treatment Open Access ESC Congress 2020

About the speaker

Photo
Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor R. De Caterina (Pisa, IT)
Video
Presentation thumbnail
How routine clinical practice data should supplement the results from clinical trials?
Professor G. Lip (Liverpool, GB)
Video
Presentation thumbnail
New insights from the ETNA-AF registry – focus on difficult-to-treat and comorbid patients.
Professor J. De Groot (Amsterdam, NL)
Video
Presentation thumbnail
Optimisation of the anticoagulation management for elderly atrial fibrillation patients.
Professor J. Steffel (Zurich, CH)
Video
Presentation thumbnail
Panel discussion.
Professor P. Kirchhof (Hamburg, DE) Professor R. De Caterina (Pisa, IT)
Video

Access the full session

Session thumbnail
How evidence from routine clinical practice can improve the care of the elderly atrial fibrillation patient?
Video

The Event

Event poster

ESC Congress 2020

30 August 2020 13:41 CET
You may be interested in
thumbnail
Congress Session
The EHJ’s year in cardiovascular medicine: cardio-oncology, heart failure, and arrhythmias
26 August 2023
thumbnail
Congress Presentation
Impact of recurrent venous thromboembolism and major bleeding events on subsequent mortality in patients with and without active cancer: Insights from the COMMAND VTE Registry-2
29 August 2026
thumbnail
Congress Presentation
Effects of low-dose dapagliflozin on heart failure–related outcomes in patients with heart failure and type 2 diabetes: a subanalysis of the dapper study
31 August 2026
thumbnail
Congress Presentation
Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources